We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current UBX market cap is 38.59M. The company's latest EPS is USD -2.3655 and P/E is -0.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.33M | -7.12M | -7.6M | -6.98M | -6.6M |
| Net Income | -15.29M | -1.5M | -5.79M | -5.28M | -6.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 33k | 4.78M | 236k | 0 |
| Operating Income | -91M | -91.3M | -56.67M | -57.57M | -39.07M |
| Net Income | -82.18M | -93.84M | -60.73M | -59.93M | -39.86M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 69.27M | 65.69M | 58.86M | 53.52M | 47.13M |
| Total Liabilities | 33.06M | 37.29M | 34.88M | 33.77M | 32.99M |
| Total Equity | 36.21M | 28.4M | 23.99M | 19.75M | 14.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 151.22M | 156.32M | 124.71M | 124.35M | 65.69M |
| Total Liabilities | 30.51M | 73.44M | 65.14M | 57.5M | 37.29M |
| Total Equity | 120.71M | 82.88M | 59.57M | 66.85M | 28.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.51M | -37.09M | -5.18M | -9.77M | -14.96M |
| Investing | 45.38M | 60.5M | -7.19M | -2.52M | 3.99M |
| Financing | -20.73M | -16.34M | N/A | 68k | 68k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -72.42M | -78.33M | -45.06M | -51.03M | -37.09M |
| Investing | 67.95M | -5.21M | 39.31M | -24.55M | 60.5M |
| Financing | 27.44M | 63.88M | 20.85M | 54.86M | -16.34M |
| Market Cap | 38.59M |
| Price to Earnings Ratio | -0.95 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.91 |
| Price to Book Ratio | 1.33 |
| Dividend Yield | - |
| Shares Outstanding | 16.85M |
| Average Volume (1 week) | 467.4k |
| Average Volume (1 Month) | 438.73k |
| 52 Week Change | 30.86% |
| 52 Week High | 2.85 |
| 52 Week Low | 0.9397 |
| Spread (Intraday) | 0.32 (12.65%) |
| Company Name | UNITY Biotechnology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unitybiotechnology.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
